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Enterococci are facultative anaerobic, nonspore-forming
Gram-positive bacteria belonging to the Lactic Acid Bacteria
(LAB) from the phylum Firmicutes. They are tolerant of a
wide range of environmental conditions, surviving in extreme
temperature, pH, and sodium chloride concentrations, being
found in soil, aquatic environment, plants, sewage, foods,
and water, and are one of the standard bacterial indicators
for the drinking and recreational water quality [1, 2]. Entero-
cocci are colonizing the gastrointestinal tract of humans and
animals (including insects and invertebrates) being part of
the gut commensal microbiota. Their name comes from the
Greek words “entero” (“έντερο”) meaning “intestine” and
“coccus” (“κόκκος”) meaning “spherical particle,” perfectly
describing their origin and morphology together [3].
For centuries, selected enterococcal species have been
widely used in the production of a variety of fermented and
nonfermented food products ranging from dairy and meat
products to vegetable and sea foods [4]. Enterococcal strains
can produce bacteriocins, some of which are heat-stable pep-
tides with low molecular weight exhibiting remarkable anti-
bacterial activities. Enterococci also have properties that are
of technological interest in the food industry, and some
strains have been used as probiotics for the maintenance of
normal intestinal microbiota, stimulation of the immune sys-
tem, and improvement of the nutritional value of foods and
feeds in humans and animals [5, 6].
However, following the emergence of antibiotic-resistant
(AMR) enterococci and particularly of the vancomycin-
resistant enterococci (VRE), these microorganisms have
turned from generally recognized as safe (GRAS) for human
consumption to significant pathogens threatening human
health and thriving in the hospital environment. According
to World Health Organization (WHO), VREs are pathogens
of high priority in the list of microorganisms for which the
development of new antimicrobials is an urgent demand [7].
Two species (E. faecalis and E. faecium) which are widely used
as probiotics have been implicated in severe infections of the
central nervous system, urinary tract, intra-abdominal and
pelvic infections, endocarditis, and bacteremia [8]. Entero-
cocci display important biological traits including the presence
of drug-resistant genes, the production of cytolysin, adhesins,
invasins, and gelatinase, which contribute to their virulence
and ability to colonize tissues [9, 10].
Thus, recently the trend of using enterococci as probio-
tics for human consumption is in debate due to the contro-
versial aspects of these bacteria which appear to be “friends
and foes” [11]. There are published studies reporting that
GRAS probiotics are causing infections, but there are no pub-
lished reports that enterococcal probiotics cause human
infections. Hence, taking into consideration the diversity of
strains within each bacterial species and the impressive
potential of the microorganisms to reorganize their genomes
Hindawi
BioMed Research International
Volume 2020, Article ID 9816185, 3 pages
https://doi.org/10.1155/2020/9816185
in their eternal effort for survival, the question whether
enterococci are beneficial probiotics or dangerous pathogens
is very intriguing andmay take long to be answered justifiably.
This special issue contains six articles reporting entero-
cocci isolation from foods and sewage sludge, the presence
of virulence genes, the antimicrobial resistance of E. faeca-
lis and E. faecium isolates from humans and food, and the
safety aspects and probiotic properties of E. faecium FL31
producing enterocin BacFL31, as well as a review summa-
rizing the pros and cons of enterococci as probiotics and
emerging pathogens.
The study by Maasjost et al. reports the presence of
virulence genes detected in enterococcal species isolated
from meat of turkeys. The isolates belonged to three spe-
cies (E. faecalis, E. faecium, and E. gallinarum) and were
examined for common virulence genes and their pheno-
typic expression. All isolates were analyzed for five selected
putative virulence traits to explore their potential role in
the pathogenicity using the chicken embryo lethality assay.
The results differ markedly between the three Enterococcus
species, with E. faecalis harboring the majority of the
investigated genes and virulence traits. From the results
of this study, it is clear that the presence or absence of vir-
ulence genes or corresponding phenotypes does not
entirely correlate with the isolates’ virulence potential
and pathogenicity for chicken embryos.
Golob et al. in their study determine and compare the
antimicrobial susceptibility and virulence traits of E. fae-
calis and E. faecium isolates from human clinical speci-
mens and retail meat (fresh beef and pork). All isolates
were investigated for susceptibility to 12 antimicrobials
using a broth microdilution method and for the presence
of seven common virulence genes using PCR. The results
are quite favorable as all isolates were susceptible to dap-
tomycin, linezolid, teicoplanin, and vancomycin with a
considerably higher proportion of susceptible isolates from
meat compared to clinical isolates (only 1.7% of meat iso-
lates were multidrug resistant compared to 42.6% of the
clinical isolates). The findings of this study show that E.
faecalis and E. faecium from red meat most likely do
not represent an important source of resistant strains to
human consumers.
Laukova et al. report the isolation of four different
enterococcal species from trouts in Slovakian water sources.
The four species (E. durans, E. faecium, E. mundtii, and E.
thailandicus) were identified using matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF-MS). The hemolytic, gelatinase, and nuclease
activity determined by cultural techniques was found nega-
tive, while the enzymatic activity tested by biochemical and
spectrophotometric methods was acceptable. All strains
possessed gene for enterocin A production, and all strains
were susceptible to antibiotics which is a very positive find-
ing. This study reports in detail the properties of entero-
cocci isolated from trout shedding more light into species
isolated from wild sources.
Another study by Laukova et al. concerns the incidence of
virulence factor genes among enterococci isolated from sew-
age sludge (cow’s dung water). Species identification of 24
enterococcal strains by ΜALDI-TOF-MS allotted 23 strains
to the species E. faecium with highly probable species identi-
fication and E. faecalis EEV20 with a score value meaning
secure genus identification/probable species identification.
Enterococci were absent of cytolysin A gene, hyaluronidase
gene, and element IS gene. It is concluded that they were
not invasive which is very important from the safety side.
According to the results of this study, the most frequently
detected gene was adhesin E. faecium (efaAfm, in 22 E. fae-
cium strains and in one E. faecalis).
The safety aspects and probiotic properties of E. faecium
FL31 strain producing enterocin BacFL31 in combination
with the aqueous peel onion (Allium cepa) extract (APOE)
in ground beef meat storage are explored in the study by Mti-
baa et al. The biopreservative effect of two natural com-
pounds (bacteriocin BacFL31 and APOE) added alone or in
combination was evaluated by microbiological, physico-
chemical, and sensory analyses during 14 days at 4°C. The
results show that the combination of APOE and BacFL31
was significantly more effective than the use of each active
compound alone, limiting the microbial deterioration,
decreasing thiobarbituric acid-reactive substances, slowing
down metmyoglobin (MetMb) and carbonyl group accumu-
lation, delaying the disappearance of sulfhydryl proteins,
inhibiting efficiently the microflora proliferation, and indi-
cating that enterocin BacFL31 derived from a safe Enterococ-
cus faecium and combined with APOE is a promising natural
preservative for ground beef.
Braїek and Smaoui review the pros and cons of entero-
cocci in view of their future use as probiotics and discuss
their dual and controversial features between opportunistic
pathogens and promising probiotics providing a useful
overview of the existing knowledge on their taxonomy,
physiological and biochemical traits, habitats, occurrence
in different foods, enterocin classification, spectrum and
mode of action, pathogenicity, virulence factors, antimicro-
bial resistance (AR), transfer of virulence factors, and AR
genes and finally discuss enterococci as probiotics.
We would like to thank all the authors for their contribu-
tions in this special issue and acknowledge all the reviewers
for their time spent in assessing the submitted manuscripts.
Also, we thank the editorial office of the BioMed Research
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